Cargando…
Low-Threshold Buprenorphine via Community Partnerships and Telemedicine—Case Reports of Expanding Access to Addiction Treatment During COVID-19
BACKGROUND: To reduce coronavirus disease 2019 (COVID-19) spread, federal agencies eased telemedicine restrictions including audio-only appointments. These changes permitted clinicians to prescribe buprenorphine to patients with opioid use disorder (OUD) without in-person or audio/video assessment....
Autores principales: | Levander, Ximena A., Wheelock, Haven, Pope, Justine, Lee, Abby, Hartmann, Kerith, Abuelkhair, Sarah, Gregg, Jessica L., Buchheit, Bradley M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815644/ https://www.ncbi.nlm.nih.gov/pubmed/34374502 http://dx.doi.org/10.1097/ADM.0000000000000811 |
Ejemplares similares
-
Low-barrier buprenorphine during the COVID-19 pandemic: A rapid transition to on-demand telemedicine with wide-ranging effects
por: Buchheit, Bradley M., et al.
Publicado: (2021) -
Utilizing telemedicine during COVID-19 pandemic for a low-threshold, street-based buprenorphine program
por: Harris, Robert, et al.
Publicado: (2022) -
Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic
por: Wang, Linda, et al.
Publicado: (2021) -
The pressing shortage of buprenorphine prescribers and the pending role of telemedicine
por: Molfenter, Todd
Publicado: (2015) -
Tobacco Addiction and Smoking Status in Heroin Addicts under Methadone vs. Buprenorphine Therapy
por: Pajusco, Benedetta, et al.
Publicado: (2012)